An 80-page Tennessee investigation released this week reconstructs how syringes prepared for joint-replacement surgery at Ascension Saint Thomas Midtown were filled with the wrong drug. Four patients were harmed. The hospital has apologized. Regulators and the state bureau of investigation are still examining what failed.
Key Takeaways by Planet Today
Confirmed event: On August 14, 2026, four of seven joint-replacement patients at Ascension Saint Thomas Midtown in Nashville received potassium phosphate instead of the intended spinal anesthetic, mepivacaine.
Documented harm: State investigators wrote that all four required a higher level of care. One remained on ECMO; three had significant lower-extremity neurologic impairment, including paralysis and loss of sensation from about mid-abdomen downward.
Where the chain broke: The 80-page survey found the wrong vial was selected, five syringes were filled and labeled as mepivacaine, barcode safeguards could be overridden, and pharmacist verification lasted about 29 seconds without a physical comparison to the record.
Regulatory status: The Tennessee Health Facilities Commission cited multiple failures, including “Immediate Jeopardy” findings. The Tennessee Bureau of Investigation has opened a case. No charges have been announced.
Hospital response: Ascension self-reported the error, apologized, and says it has isolated high-alert drugs, added dual pharmacist checks, and brought in outside quality reviewers. Families of at least one patient have spoken publicly and are consulting lawyers.
What Happened on August 14
Seven patients were on the joint-replacement schedule that Friday at the Midtown campus. According to both the hospital and the state survey, four of them received potassium phosphate rather than mepivacaine, a local anesthetic used for nerve blocks. The hospital described the event as an isolated pharmacy error and said a review found no other patients affected.
Family members of 72-year-old Glenda Dorton of Centerville, Tennessee, have said she went in for a knee replacement and later learned she had paralysis from the chest down. Local television and The Tennessean reported her relatives’ account. The hospital has not named patients, citing privacy rules.
The state report, as summarized by WKRN and WSMV, said all four affected patients needed transfer to a higher level of care. Investigators recorded that one patient remained on extracorporeal membrane oxygenation and that three continued to have significant neurologic impairment in the lower body.
Multiple patients at a Nashville hospital are paralyzed after staff accidentally gave them the wrong drugs.
— Collin Rugg (@CollinRugg) August 22, 2026
The hospital says they are "sorry" after injecting potassium chloride into the spines of people getting routine joint replacement surgeries.
Hospital staff noticed… pic.twitter.com/ZvzDgx2cdN
How Investigators Say the Wrong Drug Was Prepared
Syringes intended for nerve blocks were compounded the day before surgery, August 13. Investigators reviewed video from four camera angles in three pharmacy areas.
According to the commission’s findings as reported by WKRN, Pharmacy Technician #1 retrieved a vial of mepivacaine 2% around 10:14 a.m., then later went to a different storage bin and selected potassium phosphate. Technician #2 transferred that product into five surgical syringes and labeled them as mepivacaine. Technician #3 was supervising Technician #2, who was near the end of a probationary period and told investigators she had never mixed mepivacaine 2%.
The syringes reached a pharmacist before 11 a.m. The report states the pharmacist reviewed them but did not physically compare the product with the computer record and completed verification in about 29 seconds. The labeled syringes were then sent for use the next day.
Technician #1 later told investigators she “could not say for sure if the vial was Mepivacaine or Potassium Phosphate” and that she wished she had looked more closely. Investigators also found the pharmacy system allowed technicians to override barcode scanning and enter vial information manually, omitting identifiers such as National Drug Code and manufacturer.
What Mainstream Coverage Emphasizes
Local network affiliates and The Tennessean have treated the story as a documented patient-safety failure. Their reporting tracks three official tracks: the hospital’s own statements, the 80-page Health Facilities Commission survey, and confirmation that the Tennessee Bureau of Investigation is involved after a referral from regulators.
NewsChannel 5 reported that investigators cited problems not only in the pharmacy but also in surgical services and hospital governance, and that they recorded three “Immediate Jeopardy” findings — a regulatory term meaning conditions that place patients at immediate risk. The same reporting noted that when surveyors returned days later, potassium was still stored with other medicines and not separately identified.
Ascension’s August 27 update said some media interpretations of the CMS/state survey were inaccurate and restated that seven patients were on the schedule and four received the incorrect drug. Hospital president and CEO Dr. Shubhada Jagasia has said leaders are “deeply sorry for the harm caused.” A later hospital statement read: “Our hearts remain entirely with the four patients and families impacted… we extend our deepest apologies for the harm caused.”
What Alternative Outlets Have Added
The Gateway Pundit published a summary of the same 80-page report and the same technician and pharmacist timeline carried by Nashville television. On the core facts — wrong vial, five syringes, failed verification, patient harm, TBI referral — the alternative write-up tracks the local official record rather than introducing a separate factual claim.
Where tone differs is emphasis. Mainstream pieces focus on process failures, Immediate Jeopardy citations, and hospital corrective actions. Some alternative and social commentary has framed the case as evidence of broader hospital-system fragility and asked why high-alert drugs were stored together and why barcode overrides were possible. Those questions overlap with issues already raised by NewsChannel 5 and by pharmacy-safety experts quoted in local coverage. No public evidence in the report itself alleges intentional harm. The investigation remains open.
Hospital Changes and Open Legal Questions
Ascension says Midtown has isolated high-alert medications, including mepivacaine, in separately marked storage; added a hard-stop when a spinal-medication scan alerts; and required a second trained pharmacist for final visual and physical checks. The system also says independent quality experts are reviewing the corrective plan.
The state report, as summarized by WSMV, said the hospital did not place the involved anesthesiologist on administrative leave pending investigation and that pharmacy staff were not immediately retrained after the event. One technician involved in preparation reportedly continued working the rest of the day after patients went into crisis. Technician #1 was placed on leave August 14 and later told surveyors he did not know whether he should speak without an attorney.
As of the latest local reporting, no lawsuits had been filed, though families were consulting attorneys. The TBI investigation does not, by itself, mean criminal charges will follow. Comparisons drawn by some nursing and legal commentators to earlier Tennessee medication-error cases remain speculation until prosecutors act.
Why the Case Matters Beyond One Hospital
Hospital pharmacies sit at a narrow point in the medication chain: a single compounding and labeling error can reach several patients before anyone in the operating room sees a vial. Professional literature on high-alert drugs has long stressed physical separation, barcode integrity, and independent double checks precisely because look-alike packaging and rushed verification are known failure modes. The Nashville findings are specific to one campus and one date. They also illustrate a pattern regulators have warned about for years: software overrides, mixed storage of look-alike products, and verification that is too brief to catch a substitution.
National pharmacy surveys in 2026 continue to list shortages, staffing pressure, and workload as top concerns for hospital pharmacies. Those background stresses do not excuse a missed high-alert check. They do help explain why systems that depend on a single glance at a label remain vulnerable.
What Is Still Unknown
The public 80-page survey describes sequence, staffing, and system gaps. It does not settle final neurologic outcomes for each of the four patients. It does not name every staff member. It does not announce disciplinary or criminal results. Early family comments referred to “potassium” and, in some accounts, bupivacaine; the hospital and state documents identify the intended drug as mepivacaine and the substituted product as potassium phosphate. Readers should treat the official survey and hospital statements as the controlling record on drug identity.
Related Reading on Planet Today
Original article: Nashville Pharmacy Error Report: What Investigators Found on Planet Today 🚀
Automatically republished from the main blog.